Pharmacokinetics of Cannabidiol in Rat Brain Tissue After Single-Dose Administration of Different Formulations
Cannabidiol (CBD), a phytocannabinoid commonly isolated from chemotype III <i>Cannabis sativa</i> plants, is known for its therapeutic potential. However, comprehensive information on its bioavailability is still lacking. The key objective of this study was to investigate the impact of s...
Saved in:
| Main Authors: | Zuzana Binova, Frantisek Benes, Marie Zlechovcova, Matej Maly, Petr Kastanek, Monika Cahova, Milena Stranska, Jana Hajslova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/30/13/2676 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LC-MS/MS-Based Concurrent Quantification of Cannabidiol and Melatonin in Mouse Plasma to Elucidate Complex PK Interactions
by: Mengran Wang, et al.
Published: (2024-11-01) -
Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD)
by: Edward Chesney, et al.
Published: (2024-12-01) -
Pharmacokinetics and Dose Proportionality Study of a Novel Antiparkinsonian Agent, a 1<i>H</i>-1,2,4-Triazol-3-ylthio-conjugate of Prottremine
by: Daria S. Gorina, et al.
Published: (2024-09-01) -
Unveiling cellular changes in leukaemia cell lines after cannabidiol treatment through lipidomics
by: David Chamoso-Sanchez, et al.
Published: (2025-01-01) -
Identifying the optimal dose of cannabidiol by intrabuccal administration in Kramnik (C3HeB/FeJ) mice
by: Oluwadara Pelumi Omotayo, et al.
Published: (2025-06-01)